Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis

Hepatology

Volumn 53, Issue 2, 2011, Pages 558-566

  Montagnese, Sara ^a   Biancardi, Anna ^a   Schiff, Sami ^a   Carraro, Paolo ^b   Carlà, Vincenzo ^c   Mannaioni, Guido ^c   Moroni, Flavio ^c   Tono, Natascia ^d   Angeli, Paolo ^a   Gatta, Angelo ^a   Amodio, Piero ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; C REACTIVE PROTEIN; INDOLE; INTERLEUKIN 6; OXINDOLE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HOSPITALIZATION; HUMAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NEUROPHYSIOLOGY; NEUROPSYCHIATRY; OUTCOME ASSESSMENT; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PSYCHOMETRY; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AMMONIA; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEPATIC ENCEPHALOPATHY; HUMANS; INDOLES; INTERLEUKIN-6; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PSYCHOMETRICS; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79251517705     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.24043     Document Type: Article

References (34)

1. Schomerus H, Hamster W. Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 1998; 13: 361-377.
2. Amodio P, Valenti P, Del Piccolo F, Pellegrini A, Schiff S, Angeli P, et al. P300 latency for the diagnosis of minimal hepatic encephalopathy: evidence that spectral EEG analysis and psychometric tests are enough. Dig Liver Dis 2005; 37: 861-868.
3. Butterworth RF, Giguere JF, Michaud J, Lavoie J, Layrargues GP. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem Pathol 1987; 6: 1-12.
4. Moroni F, Carpenedo R, Venturini I, Baraldi M, Zeneroli ML. Oxindole in pathogenesis of hepatic encephalopathy. Lancet 1998; 351: 1861.
5. Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 2004; 40: 247-254.
6. Sherlock S, Summerskill WH, White LP, Phear EA. Portal-systemic encephalopathy; neurological complications of liver disease. Lancet 1954; 267: 454-457.
7. Pedersen HR, Ring-Larsen H, Olsen NV, Larsen FS. Hyperammonemia acts synergistically with lipopolysaccharide in inducing changes in cerebral hemodynamics in rats anaesthetised with pentobarbital. J Hepatol 2007; 47: 245-252.
8. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. HEPATOLOGY 2000; 32: 734-739.
9. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649.
10. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. HEPATOLOGY 2001; 33: 464-470.
11. Conn HO, Leevy CM, Vlahcevic ZR, Rodgers JB, Maddrey WC, Seeff L, et al. Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial. Gastroenterology 1977; 72: 573-583.
12. Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: 768-773.
13. Amodio P, Campagna F, Olianas S, Iannizzi P, Mapelli D, Penzo M, et al. Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. J Hepatol 2008; 49: 346-353.
14. Van der Rijt CC, Schalm SW, De Groot GH, De Vlieger M. Objective measurement of hepatic encephalopathy by means of automated EEG analysis. Electroencephalogr Clin Neurophysiol 1984; 57: 423-426.
15. Amodio P, Marchetti P, Del Piccolo F, de Tourtchaninoff M, Varghese P, Zuliani C, et al. Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin Neurophysiol 1999; 110: 1334-1344.
16. Berthier F, Lambert C, Genin C, Bienvenu J. Evaluation of an automated immunoassay method for cytokine measurement using the Immulite Immunoassay system. Clin Chem Lab Med 1999; 37: 593-599.
17. Riggio O, Mannaioni G, Ridola L, Angeloni S, Merli M, Carla V, et al. Peripheral and splanchnic indole and oxindole levels in cirrhotic patients: a study on the pathophysiology of hepatic encephalopathy. Am J Gastroenterol 2010; 105: 1374-1381.
18. Carpenedo R, Carla V, Moneti G, Chiarugi A, Moroni F. Identification and measurement of oxindole (2-indolinone) in the mammalian brain and other rat organs. Anal Biochem 1997; 244: 74-79.
19. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. HEPATOLOGY 2002; 35: 716-721.
20. Randolph C, Hilsabeck R, Kato A, Kharbanda P, Li YY, Mapelli D, et al. Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 2009; 29: 629-635.
21. Guerit JM, Amantini A, Fischer C, Kaplan PW, Mecarelli O, Schnitzler A, et al. Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 2009; 29: 789-796.
22. Amodio P, Quero JC, Del Piccolo F, Gatta A, Schalm SW. Diagnostic tools for the detection of subclinical hepatic encephalopathy: comparison of standard and computerized psychometric tests with spectral-EEG. Metab Brain Dis 1996; 11: 315-327.
23. Krabbe KS, Reichenberg A, Yirmiya R, Smed A, Pedersen BK, Bruunsgaard H. Low-dose endotoxemia and human neuropsychological functions. Brain Behav Immun 2005; 19: 453-460.
24. Myers JS, Pierce J, Pazdernik T. Neurotoxicology of chemotherapy in relation to cytokine release, the blood-brain barrier, and cognitive impairment. Oncol Nurs Forum 2008; 35: 916-920.
25. Roberts RO, Geda YE, Knopman DS, Boeve BF, Christianson TJ, Pankratz VS, et al. Association of C-reactive protein with mild cognitive impairment. Alzheimers Dement 2009; 5: 398-405.
26. Butterworth RF. The neurobiology of hepatic encephalopathy. Semin Liver Dis 1996; 16: 235-244.
27. Montagnese S, Jackson C, Morgan MY. Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis. J Hepatol 2007; 46: 447-458.
28. Saran T, Hilgier W, Urbanska EM, Turski WA, Albrecht J. Kynurenic acid synthesis in cerebral cortical slices of rats with progressing symptoms of thioacetamide-induced hepatic encephalopathy. J Neurosci Res 2004; 75: 436-440.
29. Cauli O, Rodrigo R, Piedrafita B, Boix J, Felipo V. Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts. HEPATOLOGY 2007; 46: 514-519.
30. Shawcross DL, Shabbir SS, Taylor NJ, Hughes RD. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis. HEPATOLOGY 2010; 51: 1062-1069.
31. Shawcross DL, Wright G, Olde Damink SW, Jalan R. Role of ammonia and inflammation in minimal hepatic encephalopathy. Metab Brain Dis 2007; 22: 125-138.
32. Häussinger D. Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. HEPATOLOGY 2006; 43: 1187-1190.
33. Amodio P, Pellegrini A, Amistà P, Luise S, Del Piccolo F, Mapelli D, et al. Neuropsychological-neurophysiological alterations and brain atrophy in cirrhotic patients. Metab Brain Dis 2003; 18: 63-78.
34. Campagna F, Schiff S, Ruzzoli M, Biancardi A, Raduazzo ID, Pavanello D, et al. The impact of alcohol abuse, HCV infection and liver cirrhosis on the neuropsychological and neurophysiological profile. Liver Int 2008; 28: 733.